These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of lead in gout nephropathy. Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160 [No Abstract] [Full Text] [Related]
9. [Hyperuricemia as a risk factor of nephropathy in gout]. Siniachenko OV; Diadyk AI; Nikolenko IuI; Vasilenko IV Ter Arkh; 1988; 60(1):97-101. PubMed ID: 3363519 [TBL] [Abstract][Full Text] [Related]
10. [Treatment with allopurinol in gout and hyperuricemic renal disease]. Hood B; Olander R Lakartidningen; 1973 Mar; 70(13):1297-300. PubMed ID: 4699017 [No Abstract] [Full Text] [Related]
11. [Advances in the treatment of gout and hyperuricemia]. Rapado A Rev Clin Esp; 1981 May; 161(4):269-73. PubMed ID: 7280337 [No Abstract] [Full Text] [Related]
17. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis]. Holländer E; Schwarczmann P Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966 [No Abstract] [Full Text] [Related]
18. [Changes between 1948 and 1970 in the epidemiology and clinical features of primary gout]. Babucke G; Mertz DP Dtsch Med Wochenschr; 1973 Feb; 98(5):183-8. PubMed ID: 4684527 [No Abstract] [Full Text] [Related]
19. [Ocular findings in gout and hyperuricemia]. Heinz K; Schabel F; Günther R Wien Klin Wochenschr; 1971 Jan; 83(3):42-4. PubMed ID: 5547425 [No Abstract] [Full Text] [Related]